ArticleBMC nephrology2026

Lipidomic profiling reveals medium-chain acylcarnitines alterations as metabolic signatures in IgA nephropathy.

Jiawei Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.